We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Novartis'

News List

Eli Lilly's Taltz pads case for a shot at Novartis' Cosentyx in ankylosing spondylitis fiercepharma
June 29, 2018
Eli Lilly’s Taltz is already up against Novartis’ immunology blockbuster Cosentyx in psoriasis and psoriatic arthritis. Now, Lilly looks poised to challenge the Swiss drugmaker in a third indication, too.
Senator, launching probe into Novartis' deal with Cohen, calls contract a 'corporate shakedown' fiercepharm
May 15, 2018
If Novartis thought its public statements this week would be enough to silence questions about its $1.2 million contract with President Donald Trump’s personal lawyer, Michael Cohen, it was wrong.
Novartis' Cosentyx shows almost all psoriasis patients rapidly regain skin clearance following a tre worldpharmanews
March 08, 2017
Novartis has announced a new analysis showing that moderate-to-severe psoriasis patients treated with Cosentyx® (secukinumab) rapidly regain clear or almost clear skin following relapse during a treatment pause.